These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 2423803)
1. Effects of indoramin and metoprolol on plasma lipids and lipoproteins. Martinez TL; Auriemo CR; Machado AM; Cunha MA; Feres MC; Maldjian S; Wortsman A; Delboni FO J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S76-9. PubMed ID: 2423803 [TBL] [Abstract][Full Text] [Related]
2. [Lipids, lipoproteins and apolipoproteins in normal newborns]. Casanueva V; Cid X; Chiang MT; Molina M; Ferrada MC; Pérez R; Casanueva P Rev Med Chil; 1998 Sep; 126(9):1073-8. PubMed ID: 9922510 [TBL] [Abstract][Full Text] [Related]
3. Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females. Szollár LG; Mészáros I; Tornóci L; Rischák K; Molnár M; Mányai S J Cardiovasc Pharmacol; 1990 Jun; 15(6):911-7. PubMed ID: 1694913 [TBL] [Abstract][Full Text] [Related]
4. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function. Kempen HJ; van Gent CM; Buytenhek R; Buis B J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880 [TBL] [Abstract][Full Text] [Related]
5. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol. Materson BJ; Vlachakis ND; Glasser SP; Lucas C; Ramanathan KB; Ahmad S; Morledge JH; Saunders E; Lutz LJ; Schnaper HW Am J Cardiol; 1989 Jun; 63(19):58I-63I. PubMed ID: 2567113 [TBL] [Abstract][Full Text] [Related]
6. Serum lipids and lipoproteins in type 2 diabetic patients with persistent microalbuminuria. Seghieri G; Alviggi L; Caselli P; De Giorgio LA; Breschi C; Gironi A; Niccolai M; Bartolomei GC Diabet Med; 1990 Nov; 7(9):810-4. PubMed ID: 2148134 [TBL] [Abstract][Full Text] [Related]
7. Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction. Durrington PN; Hunt L; Ishola M; Kane J; Stephens WP Br Heart J; 1986 Sep; 56(3):206-12. PubMed ID: 3092846 [TBL] [Abstract][Full Text] [Related]
8. Diurnal and monthly intra-individual variability of the concentration of lipids, lipoproteins and apoproteins. Wasenius A; Stugaard M; Otterstad JE; Frøyshov D Scand J Clin Lab Invest; 1990 Oct; 50(6):635-42. PubMed ID: 2247768 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension. Overlack A; Stumpe KO J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S53-5. PubMed ID: 2423798 [TBL] [Abstract][Full Text] [Related]
10. Serum lipids and lipoproteins in insulin-dependent diabetic patients with persistent microalbuminuria. Watts GF; Naumova R; Slavin BM; Morris RW; Houlston R; Kubal C; Shaw KM Diabet Med; 1989; 6(1):25-30. PubMed ID: 2522370 [TBL] [Abstract][Full Text] [Related]
11. Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease. Ford ES; Cooper RS; Simmons B; Castaner A J Clin Epidemiol; 1990; 43(5):425-32. PubMed ID: 2109048 [TBL] [Abstract][Full Text] [Related]
12. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics. Prager R; Schernthaner G; Kostner GM; Mühlhauser I; Zechner R; Dorda W Atherosclerosis; 1982 Jun; 43(2-3):321-7. PubMed ID: 6810904 [TBL] [Abstract][Full Text] [Related]
13. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension. Bielmann P; Leduc G; Thibault G; Lepage J; Davignon J Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):479-85. PubMed ID: 1839902 [TBL] [Abstract][Full Text] [Related]
14. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids. Baldo-Enzi G; Giada F; Zuliani G; Baroni L; Vitale E; Enzi G; Magnanini P; Fellin R Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436 [TBL] [Abstract][Full Text] [Related]
16. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E. Knopp RH; Walden CE; Warnick GR; Albers JJ; Ginsberg J; McGinnis BM Am J Med; 1987 Nov; 83(5B):75-84. PubMed ID: 3120587 [TBL] [Abstract][Full Text] [Related]
17. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
18. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man. Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553 [TBL] [Abstract][Full Text] [Related]
19. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia. Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788 [TBL] [Abstract][Full Text] [Related]
20. Short-term effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men. Taskinen MR; Kuusi T; Yki-Järvinen H; Nikkilä EA J Clin Endocrinol Metab; 1988 Aug; 67(2):291-9. PubMed ID: 3134387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]